Meglumine antimonate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis.[1] It is manufactured by Aventis[2] and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.
References
References
- ↑ PMID 9455509 (PMID 9455509)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ Aventis press release, 15 April 2005. Template:De icon
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH